MOESM1 of Prediction and clinical utility of a contralateral breast cancer risk model

Additional file 1 Table S1. Data source flowchart. Table S2. Description of the studies included in the analyses. Table S3. Patients and first primary breast cancer characteristics used in the contralateral breast cancer risk prediction model in the complete case and all case analyses. Table S4. Results of multivariable subdistributional hazard model using the complete case dataset. Table S5. List of BCAC studies (including ABCS source) with the corresponding country and geographic area. Table S6. Main patient and disease characteristics. Table S7. Clinical utility of the 5-year contralateral breast cancer risk prediction model. Table S8. Results of multivariable subdistributional hazard model for breast cancer patients without BRCA mutations. Table S9. Clinical utility of the 5-year contralateral breast cancer risk prediction model in non-BRCA tested patients. Table S10. Clinical utility of the 10-year contralateral breast cancer risk prediction model in non-BRCA tested patients.附加文件1 表S1：数据来源流程图。表S2：本分析纳入的研究概况。表S3：完整病例分析与全病例分析中，用于对侧乳腺癌风险预测模型的患者及首发性原发性乳腺癌特征。表S4：基于完整病例数据集的多变量亚分布风险模型结果。表S5：附带对应国家与地理区域的BCAC研究列表（含ABCS来源数据）。表S6：主要患者与疾病特征。表S7：5年对侧乳腺癌风险预测模型的临床应用价值。表S8：无BRCA突变乳腺癌患者的多变量亚分布风险模型结果。表S9：未接受BRCA基因检测患者的5年对侧乳腺癌风险预测模型临床应用价值。表S10：未接受BRCA基因检测患者的10年对侧乳腺癌风险预测模型临床应用价值。